CuraCore Wellness

10/03/2026

Low testosterone is often brushed off as just part of getting older.

This post covers what it is, how it’s diagnosed, and what TRT actually involves.

Read here: https://curacorewellness.com/blog/f/understanding-low-testosterone-and-trt

Low testosterone is more common than many men realize. Levels naturally decline with age, but for some, the drop is significant enough to affect energy, mood, body composition, sexual health, and overall quality of life....

08/26/2026

New post up on the blog.

Fiber is one of the most overlooked parts of nutrition—and one of the easiest things to improve without spending a fortune on supplements.

We break down the fibermaxxing trend, why getting enough fiber matters, and some simple ways to get more of it.

Every year there’s a new compound getting all the attention. Peptides, NAD+, the latest supplement everyone’s suddenly talking about. Meanwhile the intervention with some of the strongest evidence behind it costs a few d...

07/29/2026

The FDA’s advisory committee just voted on seven popular peptides, BPC-157, KPV, TB-500, MOTS-c, Semax, Epitalon, and DSIP, and the results are in.

Six were recommended for a legal compounding pathway. Only one, DSIP, was rejected. And in a surprising twist, the committee overruled its own agency’s scientists on every single vote.

Here’s the catch: this is a recommendation, not a law change. Nothing is legal to compound today that wasn’t yesterday, and the FDA still has 6-12 months of rulemaking ahead before anything actually shifts.

We broke down the full vote count, why DSIP was the one rejected, and what this actually means if you’re on a peptide protocol right now. Link below.

On July 23 and 24, the FDA’s Pharmacy Compounding Advisory Committee (PCAC) met at the agency’s White Oak campus to vote on whether seven peptides should be added to the Section 503A Bulk Drug Substances List, the roster...

07/21/2026

This week the FDA is deciding something that matters if you’re using peptides like BPC-157.

On July 23–24, the FDA’s Pharmacy Compounding Advisory Committee is reviewing seven peptides, including BPC-157, KPV, TB-500, and MOTS-c, for a formal legal pathway to compounding.

It’s not a ban vote. It’s not a legalization vote either. It’s a recommendation that, if approved, still takes 6–12 months to actually change anything.

We broke down what’s actually happening and why it matters, link in bio.

If you’re on a peptide protocol right now, this is a good week to make sure you’re working with someone who can explain the landscape, not just sell you a vial.

On July 23 and 24, the FDA’s Pharmacy Compounding Advisory Committee (PCAC) meets at the agency’s White Oak campus to review seven peptides for a formal legal pathway: BPC-157, KPV, TB-500, and MOTS-c on day one, and DSI...

07/08/2026

The peptide world may look different in just two weeks.

On July 23–24, the FDA’s Pharmacy Compounding Advisory Committee will review several of today’s most talked-about peptides, including BPC-157, KPV, TB-500, and MOTS-c. Their recommendations could have a major impact on the future of compounded peptide therapy.

With so much hype—and so much uncertainty—I thought this was the perfect time to rank today’s most popular peptides by the strength of the evidence.

Some earned an S. Some landed in F. A few may surprise you.

Read the full tier list below and let me know what you agree or disagree with.

Peptides are having a moment, and honestly, it’s deserved. This is one of the most exciting frontiers in medicine right now. Some peptide therapies are already transforming the treatment of obesity and metabolic disease,...

07/03/2026

Before you eat that second hot dog this Fourth of July, ask yourself a better question:

Do you actually know your cardiovascular risk?

One barbecue isn’t what causes heart disease. Years of cumulative risk do.

That’s why the conversation shouldn’t begin with “Should I take a statin?” It should begin with understanding your risk and making informed, individualized decisions.

Every week, someone sits down with us having already spent hours researching statins online, weighing forum posts and podcast clips against each other, without ever having had their ApoB measured. They've been debating w...

06/18/2026

There is a proposal gaining traction in elite athletics: an "Enhanced Games" where performance-enhancing drugs are used openly, under medical supervision, without pretending none of this is already happening.

Love it or hate it, it forces a question medicine has been avoiding for decades: what happens when we stop pretending the ceiling is where we have been told it is?

Most high-performing people are not sick. They are not broken. They are operating at 70% of what their biology is actually capable of — and the traditional system has nothing left for them once the labs come back "normal."

That is where CuraCore exists. Not sick care. Not fringe biohacking. Evidence-informed performance medicine that uses tools like peptides, NAD+ optimization, and targeted metabolic protocols to produce real, measurable results.

Enhancement is not a dirty word. Read the full here:

https://curacorewellness.com/blog/f/enhancement-is-not-a-dirty-word

There is a proposal circulating in elite athletics circles: an "Enhanced Games," a sanctioned competition where athletes use performance-enhancing drugs openly, under medical supervision, and compete without pretending n...

06/11/2026

Some comments on one of my recent videos got me thinking about a challenge that physicians face every day, and something that I try to do my best both with my patients and when I create educational social media content.

Many people assume medical recommendations are only justified when a bad outcome is likely, but that’s not how medicine always works.

Sometimes, we worry about common problems because they happen frequently. Other times, we worry about uncommon problems because the consequences can be severe.

That’s why we recommend seatbelts even though most car rides end safely.

It’s why we tell people not to use tap water for sinus rinses even though most people who do will never develop a serious infection.

It’s why allergists prescribe epinephrine even though most days it will never be used.

It’s why physicians generally do not recommend manipulating a pustule on the central face even though most do not develop serious complications.

One of the biggest communication challenges in medicine is that people often hear:

“This can happen”

as

“This is likely to happen.”

Those statements are not equivalent.

Good risk communication requires us to discuss both probability and consequence.

The goal isn’t fear.

The goal is helping people understand risk accurately enough to make informed decisions and to communicate issues people may not be aware of. Because medicine isn’t just about predicting what will happen most of the time.

It’s also about preventing the rare things that matter.

06/10/2026

Not every wellness clinic in Charleston is run by the person prescribing your medication. Some aren’t run by a clinician at all.

Here’s what to look for before you start treatment.

Charleston has more wellness clinics than it did a few years ago. A lot more.

06/09/2026

Concierge medicine. We come to you.

CuraCoreWellness